Gene · 5266
Papers4,558
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,558
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent Perspectives on Cardiovascular Toxicity Associated with Colorectal Cancer Drug Therapy. | Pharmaceuticals (Basel) | 2023 | 37895912 | PubTator, text mining | PubMed |
| Comparative Analysis of Redox Homeostasis Biomarkers in Patients with Psoriasis and Atopic Dermatitis. | Antioxidants (Basel) | 2023 | 37891954 | PubTator, text mining | PubMed |
| Mucosal expression of PI3, ANXA1, and VDR discriminates Crohn's disease from ulcerative colitis. | Sci Rep | 2023 | 37891214 | PubTator, text mining | PubMed |
| The Preparation and Clinical Efficacy of Amnion-Derived Membranes: A Review. | J Funct Biomater | 2023 | 37888195 | PubTator, text mining | PubMed |
| AKT Mediates Adiponectin-Dependent Regulation of VSMC Phenotype. | Cells | 2023 | 37887338 | PubTator, text mining | PubMed |
| Inflammatory response-based prognostication and personalized therapy decisions in clear cell renal cell cancer to aid precision oncology. | BMC Med Genomics | 2023 | 37885006 | PubTator, text mining | PubMed |
| Association of inflammation-related markers and diabetic retinopathy severity in the aqueous humor, but not serum of type 2 diabetic patients. | PLoS One | 2023 | 37883447 | PubTator, text mining | PubMed |
| Novel therapies for graft versus host disease with a focus on cell therapies. | Front Immunol | 2023 | 37868964 | PubTator, text mining | PubMed |
| Smart home adoption factors: A systematic literature review and research agenda. | PLoS One | 2023 | 37862296 | PubTator, text mining | PubMed |
| High WFDC3 gene expression is associated with poor prognosis and reduced immune cells infiltration in pancreatic adenocarcinoma: A study using the TCGA database and bioinformatics analysis. | Medicine (Baltimore) | 2023 | 37861515 | PubTator, text mining | PubMed |
| Gravitating towards Fintech: A study on Undergraduates using extended UTAUT model. | Heliyon | 2023 | 37860530 | PubTator, text mining | PubMed |
| Potential network markers and signaling pathways for B cells of COVID-19 based on single-cell condition-specific networks. | BMC Genomics | 2023 | 37853311 | PubTator, text mining | PubMed |
| Exosomes from umbilical cord-derived mesenchymal stem cells combined with gelatin methacryloyl inhibit vein graft restenosis by enhancing endothelial functions. | J Nanobiotechnology | 2023 | 37848990 | PubTator, text mining | PubMed |
| Cellular signaling modulated by miRNA-3652 in ovarian cancer: unveiling mechanistic pathways for future therapeutic strategies. | Cell Commun Signal | 2023 | 37845675 | PubTator, text mining | PubMed |
| Efficacy of Avène Hydrotherapy on Chronic Pruritus in Patients with Plaque Psoriasis. | Dermatol Ther (Heidelb) | 2023 | 37837493 | PubTator, text mining | PubMed |
| The Relationship between Depressive Symptoms, Quality of Life and miRNAs 8 Years after Bariatric Surgery. | Nutrients | 2023 | 37836393 | PubTator, text mining | PubMed |
| Generation of Novel Immunocompetent Mouse Cell Lines to Model Experimental Metastasis of High-Risk Neuroblastoma. | Cancers (Basel) | 2023 | 37835389 | PubTator, text mining | PubMed |
| "De Novo" Psoriasis and Relapse of Psoriasis Induced by Dupilumab: Three New Cases and Review of the Literature. | J Clin Med | 2023 | 37834935 | PubTator, text mining | PubMed |
| Atopic Dermatitis and the Risk of Myocardial Infarction and All-Cause Mortality: A Nationwide Population-Based Cohort Study. | Allergy Asthma Immunol Res | 2023 | 37827980 | PubTator, text mining | PubMed |
| Serum Elafin as a Potential Marker of Disease Activity in Behçet's Disease. | Indian J Dermatol | 2023 | 37822392 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5266/papers?page=14